European and Australian Cooperative Stroke Study II "ECASS-II"

Completed

Phase 3 Results

Summary of Purpose

To assess the safety and efficacy of intravenous thrombolysis with alteplase within 6 hours of stroke onset.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Boehringer-Ingelheim

Trial Design

Randomized, double-blind, controlled trial of 800 patients at 108 centers in Europe, Australia and New Zealand.

Contacts

Not available